Found 31 matching trials
Her2 Chimeric Antigen Receptor Expressing T Cells in Advanced Sarcoma PHASE1 Patients have a type of cancer called sarcoma. Because there is no standard...
Show More Status
Active Not Recruiting
Location
Houston Methodist Hospital
Learn More & Join Trial
Cyclophosphamide or Denileukin Diftitox Followed By Expanding a Patient's Own T Cells in the Laboratory in Treating Patients With HER-2/Neu Overexpressing Metastatic Breast Cancer, Ovarian Cancer, or Non-Small Cell Lung Cancer Previously Treated With HER-2/Neu Vaccine PHASE1 This phase I trial studies the safety and the ability to expand laboratory-...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial
Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors PHASE1 This is a multicenter, open-label, Phase 1/2 master protocol evaluating aut...
Show More Location
Peking University Shenzhen Hospital
Learn More & Join Trial
Combination Immunotherapy Targeting Sarcomas PHASE1 The aim of this clinical trial is to assess the feasibility, safety and eff...
Show More Location
Shenzhen Geno-Immune Medical Institute
Learn More & Join Trial
A Study to Evaluate Concurrent VRP-HER2 Vaccination and Pembrolizumab for Patients With Breast Cancer PHASE2 In this phase II study, participants will receive the VRP-HER2 immunization...
Show More Learn More & Join Trial
HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With Ependymoma PHASE1 This is a Phase I study to evaluate the safety profile of a type of immune ...
Show More Status
Active Not Recruiting
Location
Children's Hospital Los Angeles
Learn More & Join Trial
T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid Tumors NA RATIONALE: Studying samples of blood from patients with cancer in the labor...
Show More Location
Jonsson Comprehensive Cancer Center at UCLA
Learn More & Join Trial
Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas PHASE1 This is an open-label, non-randomized, multicenter Phase 1/2 trial evaluati...
Show More Location
District One Hospital
Learn More & Join Trial
CMV-specific Cytotoxic T Lymphocytes Expressing CAR Targeting HER2 in Patients With GBM PHASE1 This study is for patients that have a type of brain cancer called glioblas...
Show More Location
Houston Methodist Hospital
Learn More & Join Trial
Her2 and TGFBeta Cytotoxic T Cells in Treatment of Her2 Positive Malignancy PHASE1 Patients have advanced stage cancer. This study is a gene transfer research...
Show More Location
Houston Methodist Hospital
Learn More & Join Trial